Cellebrite DI [CLBT] vs Informatica [INFA] Detailed Stock Comparison

Cellebrite DI Ltd.

NASDAQ
Loading...

Informatica Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Cellebrite DI Ltd. wins in 11 metrics, Informatica Inc. wins in 9 metrics, with 0 ties. Cellebrite DI Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Cellebrite DI Ltd. Informatica Inc. Better
P/E Ratio (TTM) 42.90 826.33 Cellebrite DI Ltd.
Price-to-Book Ratio 6.83 3.12 Informatica Inc.
Debt-to-Equity Ratio 4.68 75.61 Cellebrite DI Ltd.
PEG Ratio 3.43 -6.89 Cellebrite DI Ltd.
EV/EBITDA 37.06 28.57 Informatica Inc.
Profit Margin (TTM) 16.47% 0.62% Cellebrite DI Ltd.
Operating Margin (TTM) 16.15% 13.86% Cellebrite DI Ltd.
EBITDA Margin (TTM) 16.15% 13.86% Cellebrite DI Ltd.
Return on Equity 19.10% 0.43% Cellebrite DI Ltd.
Return on Assets (TTM) 5.10% 1.96% Cellebrite DI Ltd.
Free Cash Flow (TTM) $160.32M $405.91M Informatica Inc.
1-Year Return -11.69% -5.96% Informatica Inc.
Price-to-Sales Ratio (TTM) 6.97 4.55 Informatica Inc.
Enterprise Value $2.90B $8.02B Informatica Inc.
EV/Revenue Ratio 6.10 4.78 Informatica Inc.
Gross Profit Margin (TTM) 84.71% 81.56% Cellebrite DI Ltd.
Revenue per Share (TTM) $2 $6 Informatica Inc.
Earnings per Share (Diluted) $0.31 $0.03 Cellebrite DI Ltd.
Beta (Stock Volatility) 1.28 1.14 Informatica Inc.
Short % of Float 3.52% 14.98% Cellebrite DI Ltd.

Cellebrite DI Ltd. vs Informatica Inc. Stock Performance Analysis

Loading Price Chart...

CLBT
INFA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Cellebrite DI Ltd.-5.34%11.65%3.96%3.20%-21.22%-20.52%
Informatica Inc.0.00%-0.24%-0.24%0.20%27.52%50.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Cellebrite DI Ltd.-11.69%157.97%48.79%52.48%52.48%52.48%
Informatica Inc.-5.96%42.96%-16.42%-16.42%-16.42%-16.42%

Performance & Financial Health Analysis: Cellebrite DI Ltd. vs Informatica Inc.

MetricCLBTINFA
Market Information
Market Cap i$3.18B$7.64B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i2,014,3912,702,545
90 Day Avg. Volume i1,712,4941,819,432
Last Close$14.18$24.79
52 Week Range$11.02 - $19.98$15.65 - $27.88
% from 52W High-29.03%-11.08%
All-Time High$26.30 (Feb 03, 2025)$40.13 (Dec 13, 2021)
% from All-Time High-46.08%-38.23%
Growth Metrics
Quarterly Revenue Growth0.18%0.04%
Quarterly Earnings Growth0.10%0.04%
Financial Health
Profit Margin (TTM) i0.16%0.01%
Operating Margin (TTM) i0.16%0.14%
Return on Equity (TTM) i0.19%0.00%
Debt to Equity (MRQ) i4.6875.61
Cash & Liquidity
Book Value per Share (MRQ)$1.95$7.94
Cash per Share (MRQ)$1.75$4.77
Operating Cash Flow (TTM) i$173.54M$474.32M
Levered Free Cash Flow (TTM) i$140.94M$540.00M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Cellebrite DI Ltd. vs Informatica Inc.

MetricCLBT (Apr 24, 2026)INFA (Dec 03, 2025)
Price Ratios
P/E Ratio (TTM) i42.90826.33
Forward P/E i21.8020.15
PEG Ratio i3.43-6.89
Price to Sales (TTM) i6.974.55
Price to Book (MRQ) i6.833.12
Market Capitalization
Market Capitalization i$3.18B$7.64B
Enterprise Value i$2.90B$8.02B
Enterprise Value Metrics
Enterprise to Revenue i6.104.78
Enterprise to EBITDA i37.0628.57
Risk & Other Metrics
Beta i1.281.14
Book Value per Share (MRQ) i$1.95$7.94

Financial Statements Comparison: Cellebrite DI Ltd. vs Informatica Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCLBT (2025)INFA (2024)
Revenue/Sales i475.68M1.64B
Cost of Goods Sold i75.17M326.19M
COGS % of Revenue i15.8%19.9%
Gross Profit i400.50M1.31B
Gross Margin i84.2%80.1%
Research & Development i113.88M315.16M
Operating Income (EBIT) i66.48M139.55M
Operating Margin i14.0%8.5%
EBITDA i102.33M351.02M
EBITDA Margin i21.5%21.4%
Pre-Tax Income i90.68M53.17M
Pre-Tax Income % of Revenue i19.1%3.2%
Income Tax i12.35M43.23M
Income Tax % of Revenue i2.6%2.6%
Net Income (Profit) i78.33M9.93M
Profit Margin i16.5%0.6%

Balance Sheet & Liquidity Metrics

MetricCLBT (2025)INFA (2024)
Cash & Equivalents i124.46M912.46M
Total Current Assets i575.85M1.99B
Total Current Assets % of Revenue i121.1%121.2%
Total Current Liabilities i369.66M1.09B
Total Current Liabilities % of Revenue i77.7%66.5%
Long-Term Debt i18.67M1.83B
Long-Term Debt % of Revenue i3.9%111.5%
Total Shareholders Equity i484.32M2.31B
Retained Earnings i-86.54M-1.30B
Retained Earnings % of Revenue i-18.2%-79.2%
Property, Plant & Equipment i16.95M48.44M

Cash Flow Statement Comparison

MetricCLBT (2025)INFA (2024)
Operating Cash Flow i163.74M415.37M
Operating Cash Flow % of Revenue i34.4%25.3%
Capital Expenditures i-13.23M-3.94M
Free Cash Flow i160.32M405.91M
FCF Margin i33.7%24.8%
Debt Repayment iN/A-20.72M
Common Stock Repurchase iN/A-101.85M

Short Interest & Institutional Ownership Analysis

MetricCLBTINFA
Shares Short i4.91M17.19M
Short Ratio i2.8812.28
Short % of Float i3.52%14.98%
Shares Outstanding i248.58M308.35M
Float Shares i122.90M179.25M
% Held by Insiders i43.14%1.98%
% Held by Institutions i53.29%100.18%
% Held by Public i3.57%-2.16%

Dividend Analysis & Yield Comparison: Cellebrite DI Ltd. vs Informatica Inc.

MetricCLBTINFA
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A